For the Inventor, By the Inventor

Enter assignee name

Irving, TX, United States of America

Caris Mpi, Inc.

USPTO Granted Patents = 22

% Expired Patents = 4.5

EPO Patents = 2

Trademarks = 18

Forward Citations = 193

Loading Chart...

Loading Chart...

16 inventors (with patents filed for the assignee):

Robert J Penny (17 out of 17 patents)

Daniel D Von Hoff (17 out of 20 patents)

Matthew J McGinniss (11 out of 26 patents)

4. David M Loesch (11 out of 11 patents)

5. Arlet Alarcon (11 out of 11 patents)

6. Alan Wright (11 out of 17 patents)

7. Ryan P Bender (11 out of 11 patents)

8. Traci Pawlowski (11 out of 11 patents)

9. David Spetzler (4 out of 21 patents)

10. Jim Abraham (4 out of 4 patents)

11. Wolfgang Michael Korn (4 out of 4 patents)

12. Anthony Helmstetter (2 out of 2 patents)

13. Daniel Magee (2 out of 2 patents)

14. George Poste (1 out of 7 patents)

15. Michael Klass (1 out of 7 patents)

22 patents: Sort by Forward Citations

1. 12754193 - Molecular profiling of tumors (2026-10-06),

2. 12731666 - Pan-cancer platinum response predictor (2026-09-08),

3. 12687554 - Molecular profiling of tumors (2026-07-21),

4. 12366585 - Molecular profiling of tumors (2025-07-22),

5. 12165759 - Classifying an entity for FOLFOX treatment (2024-12-10),

6. 11842805 - Pan-cancer platinum response predictor (2023-12-12),

7. 11315673 - Next-generation molecular profiling (2022-04-26),

8. 9389234 - Molecular profiling of tumors (2016-07-12),

9. 9383365 - System and method for determining individualized medical intervention for a disease state (2016-07-05),

10. 9372193 - System and method for determining individualized medical intervention for a disease state (2016-06-21),

11. 9322067 - Molecular profiling of tumors (2016-04-26),

12. 9292660 - Molecular profiling of tumors (2016-03-22),

13. 9092392 - Molecular profiling of tumors (2015-07-28),

14. 9064045 - Molecular profiling of tumors (2015-06-23),

15. 9058418 - Molecular profiling of tumors (2015-06-16),

Caris MPI, Inc. is a biotechnology company based in Irving, Texas, specializing in precision medicine and molecular profiling. The organization focuses on developing advanced diagnostic solutions that enhance personalized treatment strategies for patients, particularly in oncology. By leveraging cutting-edge technologies, Caris MPI aims to provide comprehensive insights into tumor biology, enabling healthcare providers to make informed decisions tailored to individual patient needs. Their commitment to innovation positions them as a key player in the evolving landscape of personalized healthcare.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

22 Patents

#17 in Irving, TX

#889 in Texas

#15,021 in US

#28,749 in the World

Irving, TX, United States of America

Caris Mpi, Inc.

Forward Citations = 193

16 inventors:

Robert J Penny (17 out of 17 patents)

Daniel D Von Hoff (17 out of 20 patents)

Matthew J McGinniss (11 out of 26 patents)

4. David M Loesch (11 out of 11 patents)

5. Arlet Alarcon (11 out of 11 patents)

Please report any incorrect information to [email protected]

Loading…